Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 2
Submit an article Journal homepage
6,969
Views
17
CrossRef citations to date
0
Altmetric
Hematology

Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B

Jinesh ShahCSL Behring, King of Prussia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6594-8041
ORCID Icon,
Hongseok KimCSL Behring, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0003-1964-4749
ORCID Icon,
Krupa SivamurthyCSL Behring, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0002-0487-3111
ORCID Icon,
Paul E. MonahanCSL Behring, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0003-2110-0740
ORCID Icon &
Michael FriesCSL Behring, King of Prussia, PA, USAORCID Iconhttps://orcid.org/0000-0002-3958-8775
ORCID Icon
Pages 227-237 | Received 12 Sep 2022, Accepted 05 Oct 2022, Published online: 25 Oct 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.